
Loading, please wait...

Loading, please wait...

Managing residual cement implant crowns remains a significant hurdle in restorative dentistry. Clinical experts recognize excess luting agents as a primary risk factor for peri-implantitis. A recent randomized controlled trial investigated the frequency and quantity of this excess. Specifically, researchers compared resin composite and glass ionomer cements on customized ceramic abutments. They assessed the impact of intraoral exposure times ranging from immediate removal to four weeks post-cementation.
The study involved 40 patients receiving monolithic zirconia crowns. One experienced clinician performed all cementation and excess removal procedures. Surprisingly, the analysis detected residual cement on 97.5% of the abutments. Resin composite cement left significantly more residues than glass ionomer across all measured surfaces. Furthermore, the amount of residue increased significantly when the crowns remained in the mouth for four weeks. However, factors like quadrant location or implant region did not significantly influence the results.
Consequently, the choice of cement material plays a vital role in long-term peri-implant health. Glass ionomer cements appear easier to clean and leave fewer traces behind. Therefore, clinicians must exercise extreme caution when using resin-based materials. In addition, subgingival margins tended to harbor more excess than supragingival locations. These findings highlight the inherent difficulty in achieving a completely clean environment around dental implants.
Excess cement acts as a foreign body and provides a rough surface for bacterial colonization. This can lead to localized inflammation, bone loss, and eventually peri-implantitis.
Based on recent clinical evidence, glass ionomer cement leaves significantly fewer residues than resin composite cement. This makes it a safer option for reducing the risk of peri-implant complications.
Yes, residues tend to increase or become more difficult to detect as intraoral exposure time increases. Immediate and thorough removal is essential to minimize long-term risks.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider for any medical or dental condition. Refer to the latest local and national guidelines for clinical practice.
References
Weinreuter M et al. Residual Cement Excess of Composite Versus Glass Ionomer Cement in Implant-Supported Single Crowns After Different Intraoral Exposure Times-A Randomized Controlled Clinical Trial. Clin Oral Implants Res. 2026 Mar 08. doi: 10.1111/clr.70113. PMID: 41795226.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A randomized trial finds resin composite cement leaves significantly more residues than glass ionomer in implant-supported single crowns....
7 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today